 |
 |
You've delivered great progress in the treatment and prevention of HIV in the three decades since its discovery, and slowed the rate of new infections in many countries. However, work continues in developing a safe and effective vaccine, a goal we've yet to reach due to the unique nature of the HIV-1 virus and the complex human dimensions of the infection, such as same-sex and mother-to-child transmission, the breadth of cultures involved and hard-to-treat patients. And while the use of PrEP and treatment as prevention has greatly reduced rates of transmission, its use has also had an impact on vaccine study design. You require new data, new insights and new expertise to deliver an effective HIV-1 vaccine, an indispensable component in the race to end HIV world-wide. |
 |
Join this webinar for a discussion of the progress you've made, the lessons learned, and the challenging road ahead in developing an HIV vaccine. We'll summarize recent advances in the immunopathology of HIV, encouraging new developments in vaccine research, the very limited status of pediatric studies, and why your work to develop a vaccine is more critical than ever to ending the pandemic.
|
 |
Key take-aways:
|
 |
• |
 |
Clinical trial design is especially important to the success of your HIV-1 trial, and requires that you tap a high level of expertise and experience with clinical development plans and regulatory gap analysis. |
 |
 |
• |
 |
Allowing PrEP use in trial subjects may actually accelerate your HIV-1 vaccine trial. |
 |
 |
• |
 |
With a deep understanding of Human Data Science, you can use real-world data and evidence-based support to accelerate subject selection and more precisely target sites. |
|
 |
|
 |
 |
 |
Presenters: |
 |
Paul Turner
Sr. Medical Director, Infectious Diseases and Vaccines, IQVIA |
 |
Nuria Martinez-Alier
Sr. Medical Director, Infectious Diseases and Vaccines, IQVIA |
 |
Moderator: |
 |
Lisa Henderson
Editorial Director, Applied Clinical Trials |
|
 |
 |
|
 |
For technical questions about this webinar,
please contact Kristen Moore at kristen.moore@ubm.com |
|
If you can't make the live webcast, please feel free to register and view it on-demand after the air date. |
|
 |
|
 |
Contact us at
www.iqvia.com
|
 |
|
|
 |
|